KLab is one of the pioneers in India inKLAB is a pioneer in the Indian Oncology formulations market. It has one of the widest range of Oncology formulations, which are manufactured at KLAB owned WHO-GMP approved facility at Thane, Mumbai.

LAB manufactures tablets, capsules, powder and liquid injectables.
KLAB's oncology products are now registered in more than 30 countries in Africa, Latin America, CIS and South East Asia. In India KLAB has a dedicated Oncology task force which covers Oncologists and Oncology Institutions across the length and breadth of India. Further, KLAB supplies finished ONCO formulations to a large number of Indian Companies.

ANTICANCER INJECTIONS

Bleomycin Sulphate .
Carboplatin .
Cisplatin .
Cyclophosphamide Doxorubicin Hydrochloride .
Epirubicin Hydrochloride .
Etoposide .
Methotrexate .
Docetaxel .
Gemcitabine Hydrochloride .
Vinblastine Sulphate .
Vincristine Sulphate .
Irinotecan Hydrochloride .
Fluorouracil .
Paclitaxel .
Fludarabine Lyophilised
L-Asparaginase
Oxaliplatin
Leucovorin Calcium
Pamidronate disodium
Gefitinib
Liposomal Amphotericin B
Liposomal Doxorubicin Hcl
Zoledronic Acid

TABLETS / CAPSULES

Letrozole Tablets
Methotrexate Tablets
Hydroxyurea Capsules
Tamoxifen Tablets
Bicalutamide Tablets
Imatinib Mesylate Capsules
Anastrozole Tablets
Bortezomib Tablets
Lumustine Capsules